Pharmacovigilance Software Market to Reach US$ 415.42 Million by 2033 at 7.4% CAGR; North America Leads with 43% Share - Key Players: Oracle, ArisGlobal, Ennov

The global Pharmacovigilance Software market reached US$ 218.95 million in 2024 and is projected to reach US$ 415.42 million by 2033, expanding at a CAGR of 7.4 percent during the forecast period 2025-2033. Growth is supported by the rising emphasis on post-market drug safety, increasing volumes of adverse event reports, and the need for efficient systems that help pharmaceutical companies and regulators maintain compliance with evolving global safety standards.

Pharmacovigilance software plays a critical role in monitoring medication safety once products enter the market. It streamlines the detection, reporting, and analysis of adverse events, enabling stakeholders to identify safety signals early and support timely decision-making. With capabilities such as automated reporting, integration of data from multiple sources, real-time analytics, and regulatory compliance features, these platforms enhance operational efficiency and reinforce patient safety. As the pharmaceutical landscape becomes more data-intensive, the adoption of advanced pharmacovigilance solutions is expected to continue rising across the sector.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/pharmacovigilance-software-market?sai-v

The Pharmacovigilance Software Market refers to the industry offering digital solutions that help detect, assess, monitor, and manage adverse drug reactions to ensure drug safety and regulatory compliance.

Key Developments
✅ October 2025: Major pharmaceutical companies in the U.S. expanded adoption of AI-enabled signal detection platforms to enhance early identification of adverse drug reactions (ADRs) across global clinical and post-market data streams.

✅ September 2025: European regulatory bodies implemented cloud-based pharmacovigilance reporting portals integrated with E2B(R3) standards to streamline adverse event submissions and improve compliance efficiency.

✅ August 2025: Leading PV software vendors launched next-generation automation tools that use NLP and machine learning to process case intake from medical literature, patient apps, and social media sources.

✅ July 2025: Asia-Pacific life sciences companies adopted real-time drug safety analytics dashboards to improve risk management and accelerate safety signal assessment.

✅ May 2025: Biopharma CROs deployed unified pharmacovigilance-clinical data integration systems to enhance safety monitoring during late-phase and post-approval studies.

✅ March 2025: Middle Eastern healthcare authorities expanded national ADR reporting platforms to capture digital patient-reported outcomes and strengthen public health surveillance.

Mergers & Acquisitions
✅ November 2025: A leading U.S. drug safety technology provider acquired an AI-driven medical case processing startup to automate global pharmacovigilance case workflows.

✅ August 2025: A European PV software firm formed a strategic partnership with a global CRO to co-develop cloud-native end-to-end safety management platforms.

✅ June 2025: An Asia-Pacific health-tech company acquired a pharmacovigilance analytics firm to integrate advanced signal detection capabilities into its regulatory compliance suite.

Key Players
Ennov | Oracle | ArisGlobal | EXTEDO | Clinevo Technologies | IQVIA | Quanticate | Cloudbyz | Flex Databases

Key Highlights
Ennov - Holds a 13.6% share, driven by its unified cloud-based pharmacovigilance suite, strong compliance capabilities, and expanding adoption across global life sciences companies.

Oracle - Holds a 19.4% share, supported by its industry-leading Argus Safety platform, advanced automation features, and deep integration with enterprise regulatory systems.

ArisGlobal - Holds a 17.2% share, backed by its LifeSphere Safety platform, AI-powered case processing, and expanding partnerships with pharmaceutical innovators.

EXTEDO - Holds an 8.7% share, fueled by its regulatory compliance expertise, robust signal management tools, and strong footprint in the EU life sciences market.

Clinevo Technologies - Holds a 6.1% share, driven by its cloud-native safety software, scalable PV solutions, and rising adoption among mid-sized pharma companies.

IQVIA - Holds a 14.9% share, supported by its advanced safety analytics, global PV outsourcing capabilities, and integrated real-world evidence ecosystem.

Quanticate - Holds a 5.3% share, recognized for its specialized PV services, case processing expertise, and strong presence in clinical research support.

Cloudbyz - Holds a 4.8% share, driven by its Salesforce-based PV platform, strong configurability, and rapid adoption in emerging biopharma.

Flex Databases - Holds a 3.1% share, supported by its modular safety systems, strong regulatory compliance, and growing customer base in clinical operations.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=pharmacovigilance-software-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers

- Increasing global focus on drug safety and post-market surveillance to reduce adverse drug reactions (ADRs).

- Rising volume of clinical trials and growing need for efficient safety data management.

- Regulatory requirements from FDA, EMA, and other agencies mandating robust pharmacovigilance practices.

- Expansion of pharmaceutical and biotechnology industries driving demand for automated safety monitoring tools.

- Growing adoption of cloud-based pharmacovigilance platforms for scalability and real-time reporting.

- Integration of AI, machine learning, and NLP for automated signal detection and faster case processing.

- Rising prevalence of polypharmacy and personalized medicine increasing safety monitoring needs.

Industry Developments

- Launch of AI-powered pharmacovigilance platforms enabling automated case processing and intelligent workflow management.

- Strategic collaborations between pharma companies and software providers to enhance global drug safety operations.

- Development of advanced signal detection tools leveraging predictive analytics and big data integration.

- Increasing adoption of SaaS-based PV solutions offering cost-effective compliance and scalability.

- Expansion of end-to-end safety databases that support E2B(R3) compliance, risk management, and global regulatory submissions.

- Investment in mobile-enabled adverse event reporting solutions to enhance patient and provider participation.

Regional Insights

North America - 43% share: "Driven by strong regulatory oversight, mature pharma industry, and rapid adoption of advanced PV automation tools."

Europe - 31% share: "Supported by strict drug safety regulations, growing pharmacovigilance outsourcing, and widespread use of cloud PV platforms."

Asia Pacific - 20% share: "Fueled by expanding clinical research activities, rising drug manufacturing, and increasing adoption of digital PV systems."

Latin America - 4% share: "Boosted by improving regulatory frameworks and growing pharmaceutical sector requiring efficient safety reporting."

Middle East & Africa - 2% share: "Driven by rising investment in healthcare IT and growing focus on strengthening drug safety compliance."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmacovigilance-software-market?sai-v

Key Segments

➥ By Functionality
Adverse Event Reporting Software: Enables automated collection, documentation, and submission of adverse drug reaction (ADR) data to regulatory authorities with high accuracy and compliance.

Drug Safety Audits Software: Supports auditing processes, compliance checks, safety reviews, and internal assessments to ensure adherence to global pharmacovigilance regulations.

Issue Tracking Software: Facilitates monitoring, tracking, and resolution of safety-related issues across the product lifecycle, improving workflow transparency and response time.

Fully Integrated Software: Comprehensive platforms combining reporting, auditing, risk management, analytics, and compliance modules within a single ecosystem.

➥ By Delivery Mode
On-Premise Delivery Mode: Locally installed systems offering full data control, customizable configurations, and enhanced security for organizations with strict governance requirements.

On-Demand / Cloud-Based (SaaS) Delivery Mode: Web-hosted, scalable solutions providing real-time access, automatic updates, lower maintenance costs, and seamless collaboration across global teams.

➥ By End User
Pharma and Biotech Companies: Utilize pharmacovigilance software to manage drug safety data, regulatory submissions, clinical monitoring, and post-marketing surveillance.

Contract Research Organizations (CROs): Adopt these platforms to handle large-scale safety reporting, clinical trial monitoring, and outsourced regulatory compliance efficiently.

Business Process Outsourcing (BPO) Firms: Use PV software to manage outsourced safety operations, case processing, and data management for global clients.

Other Pharmacovigilance Service Providers: Includes regulatory consultancies, academic institutions, and third-party safety monitoring organizations supporting drug safety operations.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.